-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CHe1S9hTBRw66Xv9ZbeSlPYgBlwbtCRquFA4bE6R6VlhjZklkiuXK2Bwbr1uGzVp /GAvvVY4fMGvO7NPlx6ibA== 0000055785-07-000140.txt : 20070726 0000055785-07-000140.hdr.sgml : 20070726 20070726150515 ACCESSION NUMBER: 0000055785-07-000140 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070725 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070726 DATE AS OF CHANGE: 20070726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KIMBERLY CLARK CORP CENTRAL INDEX KEY: 0000055785 STANDARD INDUSTRIAL CLASSIFICATION: CONVERTED PAPER & PAPERBOARD PRODS (NO CONTAINERS/BOXES) [2670] IRS NUMBER: 390394230 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-00225 FILM NUMBER: 071002445 BUSINESS ADDRESS: STREET 1: 351 PHELPS DRIVE CITY: IRVING STATE: TX ZIP: 75038 BUSINESS PHONE: 9722811200 MAIL ADDRESS: STREET 1: P O BOX 619100 STREET 2: DFW AIRPORT STATION CITY: DALLAS STATE: TX ZIP: 75261-9100 8-K 1 kc-8k_form.htm FORM 8-K kc-8k_form.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

_________________________________________


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report: July 23, 2007
(Date of earliest event reported)


KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)


Delaware
1-225
39-0394230
     
(State or other jurisdiction
(Commission File
(IRS Employer
of incorporation)
Number)
Identification No.)
     

 
P.O. Box 619100, Dallas, Texas
75261-9100
(Address of principal executive offices)
(Zip Code)

 
(972) 281-1200
(Registrant’s telephone number, including area code)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

______________________________________


Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On July 23, 2007, the Board of Directors of Kimberly-Clark Corporation (the “Corporation”) elected Mr. Ian C. Read to the Board of Directors, effective August 15, 2007.  Mr. Read is a Senior Vice President of Pfizer, Inc. and President of its Worldwide Pharmaceutical Operations. Mr. Read also was appointed to the Audit Committee of the Corporation’s Board of Directors effective August 15, 2007. Mr. Read will participate in the Corporation’s Outside Director Compensation Plan.

A copy of the news release announcing the election of Mr. Read to the Corporation’s Board of Directors is attached hereto as Exhibit 99.1.


Item 9.01.
Financial Statements and Exhibits.

  (d) Exhibits

 Exhibit 99.1 News release issued by Kimberly-Clark Corporation on July 25, 2007.





SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


   KIMBERLY-CLARK CORPORATION



Date:  July 26, 2007
By:  /s/ Timothy C. Everett                     
 
Timothy C. Everett
 
Vice President and Secretary
   





EXHIBIT INDEX

99.1
News release issued by Kimberly-Clark Corporation on July 25, 2007.



EX-99.1 CHARTER 2 kc-8k_readelection.htm PRESS RELEASE READ ELECTION kc-8k_readelection.htm

Exhibit 99.1

Dave Dickson
972-281-1481
ddickson@kcc.com

KIMBERLY-CLARK ELECTS PFIZER INC. SENIOR VICE PRESIDENT
IAN C. READ TO ITS BOARD OF DIRECTORS

DALLAS, July 25, 2007 — Kimberly-Clark Corporation (NYSE: KMB) today announced that Ian C. Read, senior vice president of Pfizer Inc. and president of Pfizer’s worldwide pharmaceutical operations, has been elected to its board of directors, effective August 15.
     Mr. Read, 54, has been in his current position since 2006. Pfizer is one of the world’s leading research based healthcare companies and Mr. Read is responsible for Pfizer’s global worldwide pharmaceutical business, which had 2006 revenues of $45 billion and includes major brands such as Lipitor, Celebrex and Viagra as well as new medicines for cancer (Sutent) and smoking cessation (Chantix).
     He joined Pfizer in 1978 in the company’s financial organization. As his career progressed he gained significant international experience. Mr. Read worked in Latin America through 1995, holding positions of increasing responsibility from chief financial officer in Pfizer’s Mexico operations to country manager in Brazil, home of the company’s largest subsidiary in Latin America. He was appointed president of the Pfizer International Pharmaceuticals Group, Latin America/Canada in 1996 and in 2000 was named executive vice president of Europe/Canada. Mr. Read was named a corporate vice president in 2001.
     “We are delighted that Ian Read will be joining our board,” said Linda Johnson Rice, chairman of the Nominating and Corporate Governance Committee of the Kimberly-Clark board of directors and president and chief executive officer of Johnson Publishing Company. “His understanding of today’s complex global marketplace adds valuable expertise to the board.”
    Thomas J. Falk, chairman and chief executive officer of Kimberly-Clark said, “Ian’s strong background in marketing, sales, operations and financial management, combined with his vast international experience, will greatly benefit the company as we take K-C to the next level of performance as a premier global health and hygiene company.”

      
        - more -      
    
      
        - 2 -      
    

    Mr. Read received his bachelor’s degree in chemical engineering from London University Imperial College in 1974 and earned his Chartered Accountants certification from the Institute of Chartered Accountants of England and Wales in 1978.
About Kimberly-Clark
    Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 150 countries. Every day, 1.3 billion people - almost a quarter of the world's population - trust K-C brands and the solutions they provide to enhance their health, hygiene and well being. With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds the No. 1 or No. 2 share position in more than 80 countries. To keep up with the latest K-C news and to learn more about the company's 135-year history of innovation, visit www.kimberly-clark.com.

# # #



 -----END PRIVACY-ENHANCED MESSAGE-----